{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"groups":[{"description":"Patients will receive sunitinib by mouth once a day. Treatment may continue for as long as benefit is shown.\n\nsunitinib malate: Given orally","id":"OG000","title":"Arm I"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 6 years","title":"Overall Response Rate (Complete Response, Partial Response, or Hematologic Improvement) Defined by the International Working Group Criteria","type":"PRIMARY","unitOfMeasure":"percentage of participants"}